GO:0003085 negative regulation of systemic arterial blood pressure: Physiological Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003085 describes the biological process that reduces the force with which blood travels through the systemic arterial circulatory system.
• Systemic arterial blood pressure is dynamically controlled by sympathoadrenal, circulatory, and renal mechanisms that can either raise or lower pressure.
• Genetic and environmental factors, including diabetic nephropathy susceptibility genes, influence long-term blood pressure regulation.
• Weightlessness and orthostatic stress are established experimental paradigms for studying negative regulation of arterial pressure.
• Sympathetic nerves contribute to bacterial clearance and vascular tone, linking immune function to blood pressure control.
• Cavin-1-deficient mice show arterial dysfunction but maintained systemic blood pressure, illustrating compensatory negative regulation.
Description
Systemic arterial blood pressure is the force exerted by circulating blood on the walls of large arteries, and its negative regulation is essential for preventing hypertension and end-organ damage. The Gene Ontology term GO:0003085, negative regulation of systemic arterial blood pressure, captures the biological processes that reduce this force, integrating neural, hormonal, and local vascular signals. Understanding this process is critical because impaired negative regulation underlies diverse pathologies, from orthostatic intolerance to chronic hypertension. Experimental models such as cavin-1-deficient mice have revealed that arterial dysfunction can coexist with maintained systemic pressure, highlighting compensatory negative regulatory mechanisms. Moreover, genetic studies in diabetic nephropathy have identified loci that influence blood pressure regulation, underscoring the clinical relevance of this GO term. Sympathetic nerve activity is a key modulator of both vascular tone and immune function, further linking GO:0003085 to systemic physiology. This article synthesizes authoritative QuickGO annotations and verified PubMed literature to provide a research-grade overview of the mechanisms, genes, and methods used to study negative regulation of systemic arterial blood pressure.
negative regulation of systemic arterial blood pressure At A Glance
| GO ID | GO:0003085 |
|---|---|
| GO term | negative regulation of systemic arterial blood pressure |
| Ontology | biological_process |
| Synonym | none |
| Major function | Reduces the force of blood travel through the systemic arterial circulatory system |
| Related processes | Sympathoadrenal regulation, orthostatic stress response, renal sodium handling |
| Key experimental models | Cavin-1-deficient mice, lower body negative pressure, weightlessness |
| Clinical relevance | Hypertension, orthostatic hypotension, diabetic nephropathy |
What Is GO:0003085?
GO:0003085, negative regulation of systemic arterial blood pressure, is defined as the process that reduces the force with which blood travels through the systemic arterial circulatory system. In practical terms, it encompasses any physiological mechanism that lowers arterial pressure, including decreased sympathetic outflow, vasodilation, reduced cardiac output, and increased renal sodium excretion. This process is distinct from negative regulation of blood pressure in other circuits (e.g., pulmonary), as it specifically targets the systemic arterial system.
Why Is negative regulation of systemic arterial blood pressure Important in Cell Biology?
Negative regulation of systemic arterial blood pressure is fundamental to cardiovascular homeostasis, and its failure contributes to hypertension, heart failure, and renal disease. Elucidating the genetic and physiological pathways that lower arterial pressure can reveal therapeutic targets and biomarkers for blood pressure disorders. Experimental models such as cavin-1-deficient mice and lower body negative pressure paradigms provide mechanistic insights into how the body counteracts pressor stimuli. Furthermore, sympathetic nerve activity, which modulates both vascular tone and immune function, is a critical node in this regulatory process.
• Prevents hypertension and associated cardiovascular events.
• Maintains cerebral perfusion during orthostatic stress.
• Influences renal sodium excretion and fluid balance.
• Modulated by genetic variants linked to diabetic nephropathy.
• Involved in adaptive responses to weightlessness and microgravity.
• Sympathetic nerves integrate immune and vascular control.
• Cavin-1 deficiency demonstrates dissociation between arterial function and systemic pressure.
• Provides targets for antihypertensive drug development.
• Relevant to orthostatic intolerance in aging populations.
• Key for understanding blood pressure variability in critical illness.
What Happens During negative regulation of systemic arterial blood pressure?
Neural Reflex Arc Activation
In simple terms: The brain and nerves detect high blood pressure and send signals to lower it.
Baroreceptor reflexes sense stretch in major arteries and trigger parasympathetic activation and sympathetic inhibition, reducing heart rate and vascular tone. Sympathoadrenal-circulatory regulation during orthostatic stress demonstrates rapid neural adjustments that lower arterial pressure when needed.
Vascular Smooth Muscle Relaxation
In simple terms: Blood vessels widen to decrease pressure.
Nitric oxide and other endothelial factors promote vasodilation, decreasing peripheral resistance. Cavin-1-deficient mice exhibit arterial dysfunction, yet systemic blood pressure is maintained, suggesting compensatory vasodilatory mechanisms.
Renal Sodium and Water Excretion
In simple terms: The kidneys remove excess salt and water to reduce blood volume and pressure.
Increased renal perfusion pressure promotes natriuresis, reducing circulating volume and lowering arterial pressure. Genetic factors influencing diabetic nephropathy also affect blood pressure regulation through renal mechanisms.
Hormonal Modulation
In simple terms: Hormones like atrial natriuretic peptide lower blood pressure.
Atrial natriuretic peptide and other hormones promote vasodilation and sodium excretion, contributing to negative regulation of arterial pressure. Sympathetic nerves control bacterial clearance and vascular tone, linking immune-hormonal crosstalk to blood pressure.
Adaptive Responses to Gravitational Stress
In simple terms: The body adjusts blood pressure when gravity changes, such as standing up or in space.
Lower body negative pressure and weightlessness induce fluid shifts that activate negative regulatory pathways to maintain arterial pressure. These adaptations involve cerebral blood volume changes and sympathoadrenal responses.
Key Genes Involved in GO:0003085 negative regulation of systemic arterial blood pressure
The following genes and proteins have been experimentally linked to negative regulation of systemic arterial blood pressure in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAV1 | Caveolae structural protein; arterial function | Cavin-1-deficient mice show arterial dysfunction but maintained systemic blood pressure |
| CAVIN1 | Caveolae-associated protein; vascular tone | Deficiency alters arterial function without changing systemic pressure |
| NOS3 | Endothelial nitric oxide synthase; vasodilation | Promotes negative regulation of arterial pressure via NO |
| ADRB2 | Beta-2 adrenergic receptor; vasodilation | Mediates sympathetic control of vascular tone |
| AGTR1 | Angiotensin II receptor; vasoconstriction | Counter-regulated to lower blood pressure |
| REN | Renin; angiotensinogen cleavage | Rate-limiting for angiotensin II production |
| ACE | Angiotensin-converting enzyme | Influences angiotensin II levels and blood pressure |
| NPPA | Atrial natriuretic peptide | Promotes natriuresis and vasodilation |
| NPPB | Brain natriuretic peptide | Modulates vascular tone and sodium excretion |
| EDN1 | Endothelin-1; vasoconstriction | Counteracted during negative regulation |
| PTGS2 | Cyclooxygenase-2; prostaglandins | Influences renal and vascular function |
| SLC12A3 | Thiazide-sensitive NaCl cotransporter | Regulates sodium reabsorption and blood pressure |
| WNK1 | With-no-lysine kinase 1 | Controls ion transport and blood pressure |
| ADD1 | Adducin 1; cytoskeletal protein | Genetic variants linked to hypertension |
| GNB3 | G protein beta-3 subunit | Associated with blood pressure regulation |
| CYP11B2 | Aldosterone synthase | Aldosterone affects sodium retention and pressure |
| NR3C2 | Mineralocorticoid receptor | Mediates aldosterone effects on blood pressure |
How Is negative regulation of systemic arterial blood pressure Regulated?
Negative regulation of systemic arterial blood pressure is itself regulated by feedback loops involving baroreceptors, the renin-angiotensin-aldosterone system, and sympathetic nervous activity. For example, sympathoadrenal-circulatory regulation during orthostatic stress rapidly adjusts arterial pressure through changes in heart rate and vascular resistance. Weightlessness induces adaptive responses that alter fluid distribution and sympathetic outflow, modulating negative regulatory pathways. Genetic variants in diabetic nephropathy susceptibility genes can also influence the set point for blood pressure regulation.
negative regulation of systemic arterial blood pressure and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CAVIN1 | Arterial dysfunction with maintained systemic pressure | Cavin-1-deficient mouse |
| NOS3 | Hypertension and endothelial dysfunction | Endothelial-specific knockout |
| REN | Diabetic nephropathy and hypertension | Renal knockout or knock-in |
| ADRB2 | Orthostatic hypotension | Beta-2 adrenergic receptor knockout |
| NPPA | Hypertension and cardiac hypertrophy | Nppa overexpression |
Hypertension and Cardiovascular Disease
Impaired negative regulation of systemic arterial blood pressure is a hallmark of hypertension, leading to increased risk of stroke, heart failure, and renal failure. Genetic studies in diabetic nephropathy have identified loci that contribute to blood pressure dysregulation, linking renal and cardiovascular pathologies.
Orthostatic Hypotension and Aging
Aging impairs sympathoadrenal-circulatory regulation, reducing the ability to negatively regulate arterial pressure during orthostatic stress and causing dizziness and falls. Lower body negative pressure studies reveal blunted cerebral blood volume responses in older adults.
Diabetic Nephropathy
Genetic factors influencing diabetic nephropathy also affect blood pressure regulation, and hypertension accelerates renal decline in diabetes. Negative regulation of arterial pressure is therefore a therapeutic target in diabetic patients.
Microgravity and Spaceflight Deconditioning
Weightlessness induces adaptive responses that impair negative regulation of arterial pressure upon return to Earth, causing orthostatic intolerance. These adaptations involve fluid shifts and altered sympathetic tone.
From negative regulation of systemic arterial blood pressure-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate arterial pressure? | Knockout mouse with telemetry |
| Does a point mutation alter protein function in blood pressure control? | Point-mutation knock-in mouse |
| Can overexpression of gene Y lower blood pressure? | Transgenic overexpression |
| Where is protein Z expressed in the vasculature? | Tagged knock-in with reporter |
| What is the role of gene W in renal sodium handling? | Kidney-specific knockout |
| How does gene V affect sympathetic tone? | Conditional knockout in sympathetic neurons |
How to Study the negative regulation of systemic arterial blood pressure Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Telemetry | Continuous arterial pressure | Knockout mouse phenotyping |
| Lower body negative pressure | Cerebral blood volume and orthostatic response | Human physiology studies |
| Microneurography | Sympathetic nerve activity | Orthostatic stress studies |
| Genetic association | Variant-phenotype correlations | Diabetic nephropathy cohorts |
| Echocardiography | Cardiac output and vascular resistance | Hemodynamic profiling |
| Renal clearance studies | Sodium excretion and glomerular filtration | Renal mechanisms |
| Immunohistochemistry | Protein localization in vessels | Cavin-1 studies |
Telemetry and Direct Blood Pressure Measurement
Implantable telemetry devices allow continuous monitoring of systemic arterial blood pressure in conscious, freely moving animals, providing accurate assessment of negative regulation.
Lower Body Negative Pressure (LBNP)
LBNP simulates orthostatic stress and is used in humans to study cerebral blood volume changes and sympathoadrenal responses that negatively regulate arterial pressure.
Genetic Association Studies
Candidate gene and genome-wide association studies in diabetic nephropathy cohorts have identified variants influencing blood pressure regulation.
Sympathetic Nerve Activity Recording
Microneurography and nerve recordings quantify sympathetic outflow that modulates vascular tone and negative regulation of arterial pressure.
How CRISPR Can Be Used to Study GO:0003085 negative regulation of systemic arterial blood pressure
Knockout
CRISPR knockout of candidate genes such as Cavin1 or Nos3 in mice enables assessment of their role in negative regulation of systemic arterial blood pressure using telemetry.
Point Mutation
Introducing point mutations in genes like Ren or Add1 can model human variants associated with altered blood pressure regulation.
Knock-in
Knock-in of reporter tags or human disease alleles into endogenous loci allows tracking of protein expression and function in blood pressure control.
Overexpression
CRISPR activation or transgenic overexpression of Nppa or Nos3 can test whether increased gene dosage lowers arterial pressure.
How EDITGENE Supports negative regulation of systemic arterial blood pressure Research
Researchers studying negative regulation of systemic arterial blood pressure-related genes often need to determine whether a candidate gene is causally involved in lowering arterial pressure or is merely a biomarker. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell and animal models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of systemic arterial blood pressure research.
Frequently Asked Questions About negative regulation of systemic arterial blood pressure
What is GO:0003085?
GO:0003085 is the Gene Ontology term for negative regulation of systemic arterial blood pressure, defined as the process that reduces the force with which blood travels through the systemic arterial circulatory system.
What genes are involved in negative regulation of systemic arterial blood pressure?
Key genes include CAV1, NOS3, REN, ACE, ADRB2, NPPA, and ADD1, among others, as identified in genetic and physiological studies.
How is systemic arterial blood pressure negatively regulated?
It is regulated by neural reflexes, vasodilation, renal sodium excretion, and hormonal factors that collectively lower arterial pressure.
What diseases are associated with impaired negative regulation of systemic arterial blood pressure?
Hypertension, orthostatic hypotension, diabetic nephropathy, and microgravity-induced deconditioning are associated with impaired negative regulation.
What experimental models are used to study GO:0003085?
Models include cavin-1-deficient mice, lower body negative pressure in humans, and telemetry in knockout mice.
How does weightlessness affect negative regulation of arterial pressure?
Weightlessness induces adaptive fluid shifts and altered sympathetic tone that impair the ability to negatively regulate arterial pressure upon return to gravity.
What is the role of sympathetic nerves in blood pressure regulation?
Sympathetic nerves control vascular tone and bacterial clearance, and their activity is a key modulator of negative regulation of arterial pressure.
Can CRISPR be used to study negative regulation of systemic arterial blood pressure?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of genes involved in this process.
What methods measure negative regulation of systemic arterial blood pressure?
Telemetry, lower body negative pressure, microneurography, and genetic association studies are commonly used.
Why is cavin-1 important for arterial pressure?
Cavin-1-deficient mice exhibit arterial dysfunction but maintained systemic blood pressure, suggesting compensatory negative regulatory mechanisms.
Conclusion
GO:0003085, negative regulation of systemic arterial blood pressure, is a critical biological process that integrates neural, vascular, renal, and hormonal signals to lower arterial pressure. Dysregulation of this process contributes to hypertension, orthostatic intolerance, and diabetic nephropathy, making it a key area of cardiovascular research. Experimental models such as cavin-1-deficient mice and lower body negative pressure paradigms continue to reveal novel mechanisms and therapeutic targets. CRISPR-based approaches offer powerful tools to dissect the genetic basis of this process and accelerate the development of targeted interventions.
References
- 1. Bateman RM et al.. 2016. 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.. Crit Care 20(Suppl 2):94 PMID: 27885969
- 3. Swärd K et al.. 2014. Arterial dysfunction but maintained systemic blood pressure in cavin-1-deficient mice.. PLoS One 9(3):e92428 PMID: 24658465
- 4. Norsk P. 2014. Blood pressure regulation IV: adaptive responses to weightlessness.. Eur J Appl Physiol 114(3):481-97 PMID: 24390686
- 5. Parving HH et al.. 1996. Genetics of diabetic nephropathy.. J Am Soc Nephrol 7(12):2509-17 PMID: 8989728
- 6. Whittaker JR et al.. 2019. Changes in arterial cerebral blood volume during lower body negative pressure measured with MRI.. Neuroimage 187:166-175 PMID: 28668343
- 7. Lankadeva YR et al.. 2020. Sympathetic nerves control bacterial clearance.. Sci Rep 10(1):15009 PMID: 32929135
- 8. Taylor JA et al.. 1992. Sympathoadrenal-circulatory regulation of arterial pressure during orthostatic stress in young and older men.. Am J Physiol 263(5 Pt 2):R1147-55 PMID: 1443233
